Milestone Pharmaceuticals grants 288,000 inducement stock options at $1.32 per sharePUBT·Jul 2 at 08:30 PMMIST-3.33%
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | MIST Stock NewsStockTitan·Jul 2 at 12:30 PMMIST-3.33%
Milestone Pharmaceuticals (MIST) Gets a Buy from Piper SandlerTip Ranks·May 14 at 06:17 AMMIST-3.33%BBH-0.23%
Buy Rating Reiterated on Milestone as Cardamyst Traction Grows and AFib Program Advances; $8 Price Target UnchangedTip Ranks·May 13 at 04:05 PMMIST-3.33%IHE+0.38%
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update | MIST Stock NewsStockTitan·May 12 at 10:11 PMMIST-3.33%IHE+0.38%
Milestone Pharmaceuticals Q1 2026 Earnings Call: Complete Transcriptbenzinga_article·May 13 at 08:40 AMMIST-3.33%FBT-0.57%
Sionna Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results.benzinga_article·May 12 at 10:17 AMSION+3.72%
